Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Our population of interest is patients referred from any settings for suspected, new-onset GCA. Who May Qualify: To be included in SONIC-GCA, participants must meet all the following criteria: 1. Age \> 50 years. 2. Referral to a GCA clinic for suspected, new-onset GCA. 3. Ability to understand and willingness to sign an willing to sign a consent form form. 4. Willingness to comply with study visits and procedures. Who Should NOT Join This Trial: An individual who meets any of these criteria will be excluded from SONIC-GCA: 1. Referral for a suspected GCA relapse. 2. Current use of systemic glucocorticoids, with the following duration at the baseline visit: ≥ 14 consecutive days of oral glucocorticoids in the previous 30 days, or ≥ 7 consecutive days of oral glucocorticoids if intravenous glucocorticoids were administered in the previous 30 days. 3. Current use of any conventional or biologic immunosuppressive therapy. 4. Known previous medical history of retinal diseases, optic nerve diseases, demyelinating diseases, normotensive hydrocephalus, intracranial tumors (benign or malignant), or any conditions associated with intracranial hypertension. 5. Any condition that impairs the ability to perform optic nerve sheath ultrasound or fundoscopy. Always talk to your doctor about whether this trial is right for you.